Boldrini, Luca
Chiloiro, Giuditta
Di Franco, Silvia
Romano, Angela
Smiljanic, Lana
Tran, Elena Huong
Bono, Francesco
Charles Davies, Diepriye
Lopetuso, Loris
De Bonis, Maria
Minucci, Angelo
Giacò, Luciano
Cusumano, Davide
Placidi, Lorenzo
Giannarelli, Diana
Sala, Evis
Gambacorta, Maria Antonietta
Funding for this research was provided by:
Fondazione AIRC per la ricerca sul cancro ETS (Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614, Next Generation Clinician Scientist_ID 28614)
Article History
Received: 10 July 2024
Accepted: 18 July 2024
First Online: 25 July 2024
Declarations
:
: The protocol was approved by the Ethics Committee of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS on 05 June 2023 (ethics committee identifier code 3460, prot. 17377/23). Prior to inclusion in the trial, each patient will personally sign and date a written informed consent.
: All patients recruited in the study will sign informed consent regarding publishing their data.
: Dr. Luca Boldrini and Dr. Davide Cusumano disclose previous research agreements with ViewRay Inc and received speaker honoraria for scientific presentations and travel reimbursements. Dr. Lorenzo Placidi reports a consulting agreement and previous research grants with ViewRay, outside the submitted work.